Clara Chu, MS, CCC-SLP - Speech-Language Pathologist in Woburn, MA

Clara Chu, MS, CCC-SLP is a Speech-language Pathologist based in Woburn, Massachusetts. Clara Chu is licensed to practice in Massachusetts (license number 7128) and her current practice location is 10j Gill St, Woburn, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (781) 932-2888.

NPI number for Clara Chu is 1023291721 and her current mailing address is 10j Gill St, Woburn, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023291721.

Contact Information

Clara Chu, MS, CCC-SLP
10j Gill St,
Woburn, MA 01801-1721
(781) 932-2888
Not Available



Healthcare Provider's Profile

Full NameClara Chu
GenderFemale
SpecialitySpeech-language Pathologist
Location10j Gill St, Woburn, Massachusetts
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1023291721
  • Provider Enumeration Date: 12/17/2007
  • Last Update Date: 12/17/2007

Medical Identifiers

Medical identifiers for Clara Chu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023291721NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 7128 (Massachusetts)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Clara Chu is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Clara Chu, MS, CCC-SLP
10j Gill St,
Woburn, MA 01801-1721

Ph: (781) 932-2888
Clara Chu, MS, CCC-SLP
10j Gill St,
Woburn, MA 01801-1721

Ph: (781) 932-2888

News Archive

New study identifies potential target for colorectal cancer treatment

A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.

Researchers report first-ever link between noradrenergic neurons and vulnerability to depression

The team of Bruno Giros, a researcher at the Douglas Mental Health University Institute and professor of psychiatry at McGill University, reports the first-ever connection between noradrenergic neurons and vulnerability to depression. Published in the journal Nature Neuroscience, this breakthrough paves the way for new depression treatments that target the adrenergic system.

Nucletron to present innovative cancer treatment during ESTRO29

Nucletron, a leading provider of state of the art radiotherapy solutions for cancer treatment, today announced a large number of exciting innovations for precise cancer treatment that will be in the spotlight during ESTRO29 in Barcelona. The company will be showcasing the latest developments in cancer treatment solutions for both brachytherapy and external beam.

Mindfulness may naturally develop with time and life experience, study suggests

People say life gets better with age. Now research suggests this may be because older people have the wisdom and time to use mindfulness as a means to improve wellbeing.

Read more News

› Verified 4 days ago


Speech-Language Pathologist in Woburn, MA

Bg Speech Therapy Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 576 Main St, Woburn, MA 01801
Phone: 781-710-8111    
Tracy Caron, M.A. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 10j Gill St, Woburn, MA 01801
Phone: 781-932-2888    
Michael Maerten,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 7 Burlington St, Apt.1, Woburn, MA 01801
Phone: 716-480-7887    
Jessica L. Donovan, MS, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 8 Henshaw St, F, Woburn, MA 01801
Phone: 781-935-3855    
Arielle Nicole Bear Bloom,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 10j Gill St, Woburn, MA 01801
Phone: 612-790-8223    
Miss Flinn Bingham Esselstyn,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 10p Gill St, Woburn, MA 01801
Phone: 781-932-2888    Fax: 781-932-9809

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.